Easyjet foresees losses in 2020 close to 1 billion euros
Over 7,000 Scientists, Doctors Call For COVID Herd Immunity, End To Lockdowns
Gilead Inks EU Supply Deal For 500,000 Remdesivir Doses
Government needs strategy to kick-start R&D after COVID, says pharma body
Consumers spent a record $28 billion in apps in Q3, aided by pandemic
How coronavirus has hit the UK's creative industries
Alphatec Pops 21% On 3Q Sales Guidance Beat; Street Says Buy
Company of the Year 2020: Bristol-Myers Squibb — Patience Rewarded
UK prepares to walk on October 15, but EU still positive
Gilead 2020: HIV … and COVID?
Amgen 2020: 40-Year-Old Pioneer
AstraZeneca 2020: Driven by Covid-19
AbbVie 2020: Beyond Humira
The 2020 Outcomes Creativity Index (OCI)
Harris and Pence dodge tough questions in VP debate – experts react
Eli Lilly Files For FDA Emergency Use Of COVID-19 Antibody Treatment
Takeda 2020: The incredible growing/shrinking pharma
Sanofi 2020: New challenges
Pfizer 2020: Cancer and COVID-19
Roche 2020: Built for innovation
Pollinator monitoring more than pays for itself
Top Fed Economist Says Another $3.5 Trillion In QE Needed
Watch: Russia Conducts Rare Ship-Launched Hypersonic Missile Test On Putin's Birthday
VP Debate Post-Mortem: Pence Trounces "Gaffe Machine" Harris
Nobel Prize for chemistry honors exquisitely precise gene-editing technique, CRISPR – a gene engineer explains how it works
Despite "Craving For Normalcy", Here Are Nine Reasons Why Trump May Still Win
Kissinger Warns: China-US Must Agree To "Limits" On Making Threats Or Risk War
Hurricane Delta To Strike Gulf Coast Friday
Regeneron Shares Jump After Trump Calls COVID Treatment "A Cure"
3 "Perfect 10" Stocks With Momentum on Their Side